Navigation Links
Cadence Pharmaceuticals Reports First Quarter 2013 Financial Results
Date:5/2/2013

V Prescribing Information, available at www.OFIRMEV.com or www.cadencepharm.com.

Non-GAAP Financial Measures This press release provides financial measures for net revenue, cost of sales, gross margin, net loss and basic and diluted loss per share that exclude specifically identified non-routine items, and are therefore not calculated in accordance with accounting principles generally accepted in the United States ("GAAP"). Management believes that these non-GAAP financial measures provide meaningful supplemental information regarding its performance that enhances management's and investors' ability to evaluate and compare Cadence's operating results.

These non-GAAP financial measures are not intended to be used in isolation and should not be considered a substitute for any other performance measure determined in accordance with GAAP. Investors and potential investors are cautioned that there are material limitations associated with the use of non-GAAP financial measures as an analytical tool, including that other companies may calculate similar non-GAAP financial measures differently than Cadence, limiting their usefulness as a comparative tool. Cadence compensates for these limitations by providing specific information regarding the GAAP amount excluded from the non-GAAP financial measures. Cadence further compensates for the limitations of its use of non-GAAP financial measures by presenting comparable GAAP measures more prominently. Investors and potential investors are encouraged to review the calculation of non-GAAP financial measures contained within this press release with Cadence's GAAP net income and basic and diluted loss per share.

About Cadence Pharmaceuticals, Inc.Cadence Pharmaceuticals is a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting.
'/>"/>

SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Cadence Pharmaceuticals Reports Second Quarter 2012 Financial Results
2. Cadence Pharmaceuticals To Present At The Deutsche Bank Securities, Inc. 37th Annual Health Care Conference In Boston On May 8, 2012
3. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2011 Financial Results on March 12, 2012
4. Valeant Pharmaceuticals Announces Extension of the Expiration Date for Its Previously Announced Tender Offer for All Outstanding Shares of Common Stock of Obagi Medical Products, Inc.
5. VentiRx Pharmaceuticals Appoints James Kyle Bryan, M.D. as Chief Medical Officer
6. Aurigenes Collaboration Programs with Endo Pharmaceuticals Reach Important Milestones
7. Vanda Pharmaceuticals Appoints Dr. Paolo Baroldi As Chief Medical Officer
8. Next Silicon Valley BioTalks Tackles “Is EDC Becoming a Commodity?” at Onyx Pharmaceuticals HQ
9. Global Nuclear Medicine / Radiopharmaceuticals Market worth $5.55 Billion by 2017
10. US Radiopharmaceuticals (USR) Awards Contract to Von Gahlen International for New Technetium-99m Generator Production Line Using Low Enriched Uranium Molybdenum-99
11. Anthera Pharmaceuticals Reports 2012 Fourth Quarter And Fiscal Year Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... PARK, Calif. , July 24, 2014 ... seven-year contract with the National Institute of Allergy and ... Health, to conduct preclinical development of potential therapies for ... of drugs to treat HIV and AIDS and the ... well as microbicides for preventing sexual transmission of HIV. ...
(Date:7/24/2014)... -- Neogen Corporation (Nasdaq: NEOG ) advised market ... from new rodenticide research are premature. In its regular ... 22, 2014, Neogen,s CEO commented about several new developments ... "It was my intent Tuesday at our conference call ... type of rodenticide, but certainly not to give any ...
(Date:7/24/2014)... Francisco, CA (PRWEB) July 24, 2014 ... http://www.draperuniversity.com , is proud to announce that ... from 17 different countries will converge on the ... Valley for an intensive, experiential program focused on ... The highly selective school, currently running its sixth ...
(Date:7/24/2014)... July 24, 2014 The patent ... molecular diagnostic test results. It also enables true ... the validation and reporting of high profile assays ... is a rapidly growing area of biotechnology that ... predisposition, cancer, and companion diagnostics in personalized medicine. ...
Breaking Biology Technology:National Institute of Allergy and Infectious Diseases Awards SRI International Contract to Study New Therapies for HIV and AIDS 2National Institute of Allergy and Infectious Diseases Awards SRI International Contract to Study New Therapies for HIV and AIDS 3Neogen comments on SenesTech 2Summer Entrepreneurship Program Kicked Off by Draper University in Silicon Valley 2Summer Entrepreneurship Program Kicked Off by Draper University in Silicon Valley 3New DNA-barcode Patent Virtually Eliminates False Test Results and Sample Mix-up 2
... LANSING, Mich., Oct. 15 Forbes Magazine has,named Neogen ... of the 200 Best,Small Companies in America for the ... years., "Conventional wisdom would have investors flee small-cap ... safer bets, the thinking,goes. Maybe not right now with ...
... /PRNewswire/ - Norgen Biotek Corp., an innovative,Canadian biotechnology ... acids and protein purification, today announced the,launch of ... acids from,environmental samples, the Soil DNA Isolation Kit ... ideal for environmental microbiological,studies, and provide high quality, ...
... is promoting its new PadLock Set Saver product at ... Lake City,UT, at The Salt Palace, October 15-17, 2008., ... promoting,its new PadLock Set Saver at the ANCC National ... IV administration set storage,solution, PadLock provides a secure seal ...
Cached Biology Technology:Neogen Honored by Forbes; Two Brokerage Firms Initiate Coverage 2High-quality DNA/RNA from Microorganisms in Environmental Samples 2Baxa Corporation Features PadLock(R) Set Saver at the ANCC National Magnet Conference(TM) 2
(Date:7/24/2014)... Conn. , July 24, 2014 NXT-ID, Inc., ... m-commerce market, announces its next generation smart wallet, Wocket™, was recently ... Anita Finley interviewed Gino Pereira , ... over thirty minutes. Mr. Gino ... bulky wallets full of credit cards and walks host ...
(Date:7/23/2014)... twins has found that early reading skill might positively ... Child Development , was conducted by researchers at ... "Since reading is an ability that can be improved, ... Stuart J. Ritchie, research fellow in psychology at the ... of reading problems might aid not only the growth ...
(Date:7/23/2014)... about the crow and the pitcher, a thirsty bird happens ... drink from it, he finds the water level out of ... the bird drops pebbles into it one at a ... to drink his fill. , Highlighting the value of ingenuity, ... effective than brute force. It also characterizes crows as pretty ...
Breaking Biology News(10 mins):Boomer Times Gets to Know NXT-ID's Next Generation Wocket Smart Wallet; Practical, Secure and Easy to Use 2Boomer Times Gets to Know NXT-ID's Next Generation Wocket Smart Wallet; Practical, Secure and Easy to Use 3Boomer Times Gets to Know NXT-ID's Next Generation Wocket Smart Wallet; Practical, Secure and Easy to Use 4Stronger early reading skills predict higher intelligence later 2Smarter than a first-grader? 2Smarter than a first-grader? 3Smarter than a first-grader? 4
... SUNNYVALE, California, September 29, 2010 ... ... ... keyed by longUrl, so we need to grab the first one. for (var r in data.results) { ...
... This release is also available in Chinese on ... 2010) -- The second law of thermodynamics is a big ... existential crunch. The tendency of a closed systems to become ... a popular, if not depressing, "things fall apart" sort-of-law that ...
... COLD SPRING HARBOR, N.Y. (Sept. 28, 2010) -- A ... in Gene Regulation , reviews our understanding of two RNA ... was both information store and biocatalyst; and the contemporary RNA ... host of other RNAs operate. "[T]he plasticity ...
Cached Biology News:HCL Technologies Launches AeroPASS Airport Security Solution 2HCL Technologies Launches AeroPASS Airport Security Solution 3HCL Technologies Launches AeroPASS Airport Security Solution 4HCL Technologies Launches AeroPASS Airport Security Solution 5HCL Technologies Launches AeroPASS Airport Security Solution 6HCL Technologies Launches AeroPASS Airport Security Solution 7HCL Technologies Launches AeroPASS Airport Security Solution 8HCL Technologies Launches AeroPASS Airport Security Solution 9Tiny generators turn waste heat into power 2New book reviews ancient and modern worlds of RNA 2
... and antibody-based immunoaffinity matrices, such as ... times without compromising antigen-antibody reactivity, the ... agents has precluded the application of ... The CHEMICON Re-Blot Plus Western Blot ...
Applications: Western blotting ...
Applications: Western blotting ...
...
Biology Products: